Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review.
Yingying ShenYuzhu LiHangchao LiQi LiuHuijie DongBo WangBaodong YeShenyun LinYiping ShenDijiong WuPublished in: Infection and drug resistance (2021)
Monocytopenia and mycobacterial infection (MonoMAC) syndrome is a rare disease. Herein, we reported a 65-year-old Asian woman, previously diagnosed with myelodysplastic syndrome (MDS), suffering from recurrent pneumonia, intermittent fever, fatigue, and chest tightness lasting for five months. She was ultimately diagnosed with MonoMAC syndrome with Mycobacterium kansasii (M. kansasii) infection and GATA2 mutation through metagenomic generation sequencing (mNGS) of peripheral blood specimen, for which she was given anti-NTM therapy. Her situation significantly improved within 2 weeks of therapy. We discussed the clinical features, genetic characteristic, and prognosis of this disorder, aiming to further elucidate this rare syndrome. For MDS/AML patient with recurrent mixed infection and pancytopenia (especially with monocyte absence), MonoMAC syndrome should be highly suspected, and germline mutation and pathogen sequencing should be performed.
Keyphrases
- case report
- peripheral blood
- mycobacterium tuberculosis
- transcription factor
- stem cells
- pulmonary embolism
- single cell
- gene expression
- dna repair
- depressive symptoms
- acute lymphoblastic leukemia
- endothelial cells
- immune response
- mesenchymal stem cells
- bone marrow
- candida albicans
- high intensity
- dna damage
- cell therapy
- sleep quality
- smoking cessation
- antibiotic resistance genes
- respiratory failure
- wild type
- circulating tumor